HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE
Go back to HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 107.57 +0.57 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.00 | 52 Week High | $18.39 | |||
| Open | $107.96 | 52 Week Low | $6.96 | |||
| Day High | $108.23 | P/E | N/A | |||
| Day Low | $106.34 | EPS | $-0.58 | |||
| Volume | 322,391 | |||||
